[HTML][HTML] Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells

S Ohno, M Takanashi, K Sudo, S Ueda, A Ishikawa… - Molecular therapy, 2013 - cell.com
S Ohno, M Takanashi, K Sudo, S Ueda, A Ishikawa, N Matsuyama, K Fujita, T Mizutani…
Molecular therapy, 2013cell.com
Despite the therapeutic potential of nucleic acid drugs, their clinical application has been
limited in part by a lack of appropriate delivery systems. Exosomes or microvesicles are
small endosomally derived vesicles that are secreted by a variety of cell types and tissues.
Here, we show that exosomes can efficiently deliver microRNA (miRNA) to epidermal growth
factor receptor (EGFR)-expressing breast cancer cells. Targeting was achieved by
engineering the donor cells to express the transmembrane domain of platelet-derived …
Despite the therapeutic potential of nucleic acid drugs, their clinical application has been limited in part by a lack of appropriate delivery systems. Exosomes or microvesicles are small endosomally derived vesicles that are secreted by a variety of cell types and tissues. Here, we show that exosomes can efficiently deliver microRNA (miRNA) to epidermal growth factor receptor (EGFR)-expressing breast cancer cells. Targeting was achieved by engineering the donor cells to express the transmembrane domain of platelet-derived growth factor receptor fused to the GE11 peptide. Intravenously injected exosomes delivered let-7a miRNA to EGFR-expressing xenograft breast cancer tissue in RAG2–/– mice. Our results suggest that exosomes can be used therapeutically to target EGFR-expressing cancerous tissues with nucleic acid drugs.
cell.com